Latest in Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
Sort by
1,151 items
-
Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
The pharma company raised its guidance on revenue growth from its key treatments and expected drug launches, and now anticipates annual currency-adjusted sales to grow by 6% through 2028.Business - The Wall Street Journal - 9 hours ago -
Novartis Lifts Guidance Again After Key Drugs Help Results
The pharmaceutical giant raised its full-year guidance for the third time this year after higher third-quarter profit and sales topped analysts’ expectations, boosted by revenue from its key drugs.Business - The Wall Street Journal - October 29 -
Why gold is a key asset in recession-proof portfolios
Think a recession is coming? Here's why you may want to buy gold.Top stories - CBS News - October 23 -
ING Lifts Outlook After Profit Beat
ING raised its total income outlook for the year and said it would distribute up to $2.7 billion to shareholders after net profits topped expectations.Business - The Wall Street Journal - October 31 -
Siemens Energy Lifts Outlook on Power Demand Boom
Siemens Energy raised its midterm targets as the energy company bets on a boom in global power demand helped by rising electrification, industrial decarbonization and AI applications.Business - The Wall Street Journal - November 13 -
Deutsche Telekom Lifts Outlook After Profit Beat
The telecoms group raised its full-year guidance for a key earnings metric after reporting higher net profit in the third quarter, citing continued growth momentum on both sides of the Atlantic.Business - The Wall Street Journal - November 14 -
Aegon Lifts Outlook, Launches $158 Million Buyback
The financial services company raised its full-year guidance and said it expected to start buying back shares in January.Business - The Wall Street Journal - 6 days ago -
Unilever Backs Outlook After Sales Growth
The consumer goods giant reiterated its full-year guidance after underlying sales grew more than expected in the third quarter as shoppers welcomed easing price hikes and began buying more of the ...Business - The Wall Street Journal - October 24 -
Mattel Lowers Sales Outlook After Barbie Sales Weigh
The toy company’s profit, however, is holding up due to stronger margins, helped by factors such as cost cuts, supply-chain improvements and lower input costs.Business - The Wall Street Journal - October 23 -
Eni Cuts Profit Outlook on Weak Prices, Lifts Buybacks
Eni lowered its guidance for the year due to a decline in oil prices which also hit the Italian energy major’s third-quarter profits, but said it planned to increase its share buy backs.Business - The Wall Street Journal - October 25 -
Unilever reiterates 2024 outlook after third-quarter sales growth
Unilever on Thursday reiterated its 2024 outlook after reporting underlying sales growth of 4.5% in the third quarter.Business - MarketWatch - October 24 -
Philips shares slide as company blames China for lowered sales outlook
Shares of Philips slumped on Monday as the Dutch healthcare devices company lowered its sales outlook for the year.Business - MarketWatch - October 28 -
EBay’s sales outlook comes in weaker, and stock falls more than 7%
EBay’s slightly better-than-expected quarterly earnings were no match for a weaker sales outlook.Business - MarketWatch - October 31 -
Tapestry’s stock climbs on sales and earnings beat, raised outlook
Tapestry’s first-quarter revenue was fueled by topline growth at Coach.Business - MarketWatch - November 7 -
Advance Auto Parts to Close Stores as Sales Outlook Misses Views
Advance Auto Parts said it will close hundreds of stores and cut jobs after posting a surprising quarterly loss and forecasting revenue below market expectations.Business - The Wall Street Journal - November 14 -
Walmart sales beat again and outlook raised, as retailer cites ‘resilient’ US customers
Walmart’s stock headed for a record after another earnings beat, as general merchandise sales turned positive.Business - MarketWatch - 2 days ago -
The Key to Boosting Sales: Identifying and Converting Non-Customers
Not everyone is a customer. And you need to examine the types of non-customers you have to understand why.Business - Inc. - October 26 -
American Airlines lifts 2024 profit forecast after sales strategy shift, posts third-quarter loss
American Airlines raised its profit forecast for the year as CEO Robert Isom said the company's sales strategy shift earlier this year is paying off.Business - CNBC - October 24 -
Japanese lift maker Fujitec explores sale to private equity
Talks with multiple groups including Sweden’s EQT have taken place in recent monthsWorld - Financial Times - October 30 -
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.Business - CNBC - October 31 -
Starbucks shares slide after coffee chain says sales fell again, suspends outlook
The company's same-store sales slid for the third consecutive quarter, fueled by a 10% tumble in traffic to its North American stores.Business - CNBC - October 23 -
Intel Posts More Than $16 Billion Loss but Says Sales Outlook Is Improving
The chip maker attributed nearly $16 billion in charges to its sweeping restructuring efforts. The company’s rosy sales forecast sent shares up about 8% after hours.Business - The Wall Street Journal - October 31 -
Applied Materials Offers Modest Sales Outlook on Slowdown of Chinese Market; Shares Fall
Applied Materials forecasts revenue growth of between 8% and 12% across its core semiconductor-systems business and its applied global-services segment, respectively, but also a 28% drop in display ...Business - The Wall Street Journal - 6 days ago -
-
‘People didn’t believe Africa could be a source of innovation’: how the continent holds the key to future drug research
Prof Kelly Chibale says the world is failing to take advantage of African genetic diversity, and everyone could be losing out. Africa has the greatest variety in human genes anywhere on the planet ...World - The Guardian - October 28 -
JD Vance’s Senate Office Fires Key Adviser Who Posted About Drug Use on Reddit
“Those posts were written in good humor and didn't hurt anybody,” says Aaron Kofsky, who advised Vance on crypto and banking policy, of posts in which he wrote about using cocaine, kratom, and ...Tech - Wired - November 4 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.Business - CNBC - October 31 -
Apple Intelligence is key to new iPhone sales, but don’t expect a big revenue jolt right away
With Monday’s rollout of Apple Intelligence on Apple Inc.’s newest iPhones, investors need to remember that the addition of generative artificial intelligence is unlikely to immediately lead to a ...Business - MarketWatch - October 28 -
-
-
Uganda targets 2027 start for world’s longest heated oil pipeline
Financing delays blamed on protests will not derail crude project, says minister at COP climate summitWorld - Financial Times - Yesterday -
Buy British? My unpatriotic portfolio shame
Should I be denounced for spurning UK domestic assets?World - Financial Times - October 23 -
Why gold still shines in modern portfolios
Gold is a strategic tool utilized for multiple purposes. Here's why it's still valuable in modern portfolios.Top stories - CBS News - October 29 -
Reddit has sold most of its cryptocurrency portfolio
Reddit’s proceeds from the crypto sale were $6.9 million during the quarter, according to a filing.Business - MarketWatch - October 30 -
Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
Schrödinger will receive $150 million upfront plus up to $2.3 billion in milestone and royalty payments.Business - MarketWatch - November 12
